| Dr Michael Brooks Pipestone, MD | |
|
801 Ostrum St, St Luke's Enrollment Center, Bethlehem, PA 18015-1000 | |
| (484) 526-3285 | |
| (484) 526-6500 |
| Full Name | Dr Michael Brooks Pipestone |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 14 Years |
| Location | 801 Ostrum St, Bethlehem, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043537038 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Home Health | Bethlehem, PA | Home health agency |
| St Luke's Hospital Bethlehem | Bethlehem, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Luke's Physician Group Inc | 6709798333 | 1739 |
News Archive
HealthPort, the industry authority on the HIPAA-compliant exchange of protected health information through release of information services and audit management technology, today announced that the Company is the first Health Information Handler (HIH) to successfully transmit records via the Centers for Medicare and Medicaid Services' (CMS) electronic submission of medical documentation (esMD) gateway for information exchange from healthcare providers, once again leading the way in release of information innovation.
Type 2 diabetics inject themselves with insulin, a hormone that regulates the movement of sugar into liver, muscle and fat cells, up to four times a day. But insulin injections are linked to weight gain and the loss of control of blood sugar levels. This triggers a vicious cycle of higher insulin doses, continuous weight gain, a higher incidence of cardiovascular disease and other complications.
Biocept, Inc., a leading commercial provider of clinically actionable liquid biopsy tests designed to improve the outcomes of cancer patients, announces that Columbia University Medical Center will conduct a study to evaluate the clinical utility of the Company's Target Selector™ platform to diagnose leptomeningeal metastases (LM) in patients with breast cancer.
Many of the most aggressive and hard-to-treat cancers are highly effective at blocking T cells, known as the foot soldiers of the immune system, from reaching and responding to tumors.
High levels of two specific vaginal bacteria (Atopobium vaginae and Gardnerella vaginalis) serve as diagnostic markers of an abnormal vaginal microbiota that might cause impaired implantation and subsequent poor reproductive outcome.
› Verified 7 days ago
| Entity Name | St Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700984622 PECOS PAC ID: 6709798333 Enrollment ID: O20040226000062 |
News Archive
HealthPort, the industry authority on the HIPAA-compliant exchange of protected health information through release of information services and audit management technology, today announced that the Company is the first Health Information Handler (HIH) to successfully transmit records via the Centers for Medicare and Medicaid Services' (CMS) electronic submission of medical documentation (esMD) gateway for information exchange from healthcare providers, once again leading the way in release of information innovation.
Type 2 diabetics inject themselves with insulin, a hormone that regulates the movement of sugar into liver, muscle and fat cells, up to four times a day. But insulin injections are linked to weight gain and the loss of control of blood sugar levels. This triggers a vicious cycle of higher insulin doses, continuous weight gain, a higher incidence of cardiovascular disease and other complications.
Biocept, Inc., a leading commercial provider of clinically actionable liquid biopsy tests designed to improve the outcomes of cancer patients, announces that Columbia University Medical Center will conduct a study to evaluate the clinical utility of the Company's Target Selector™ platform to diagnose leptomeningeal metastases (LM) in patients with breast cancer.
Many of the most aggressive and hard-to-treat cancers are highly effective at blocking T cells, known as the foot soldiers of the immune system, from reaching and responding to tumors.
High levels of two specific vaginal bacteria (Atopobium vaginae and Gardnerella vaginalis) serve as diagnostic markers of an abnormal vaginal microbiota that might cause impaired implantation and subsequent poor reproductive outcome.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Brooks Pipestone, MD 801 Ostrum St, St Luke's Enrollment Center, Bethlehem, PA 18015-1000 Ph: (484) 526-3285 | Dr Michael Brooks Pipestone, MD 801 Ostrum St, St Luke's Enrollment Center, Bethlehem, PA 18015-1000 Ph: (484) 526-3285 |
News Archive
HealthPort, the industry authority on the HIPAA-compliant exchange of protected health information through release of information services and audit management technology, today announced that the Company is the first Health Information Handler (HIH) to successfully transmit records via the Centers for Medicare and Medicaid Services' (CMS) electronic submission of medical documentation (esMD) gateway for information exchange from healthcare providers, once again leading the way in release of information innovation.
Type 2 diabetics inject themselves with insulin, a hormone that regulates the movement of sugar into liver, muscle and fat cells, up to four times a day. But insulin injections are linked to weight gain and the loss of control of blood sugar levels. This triggers a vicious cycle of higher insulin doses, continuous weight gain, a higher incidence of cardiovascular disease and other complications.
Biocept, Inc., a leading commercial provider of clinically actionable liquid biopsy tests designed to improve the outcomes of cancer patients, announces that Columbia University Medical Center will conduct a study to evaluate the clinical utility of the Company's Target Selector™ platform to diagnose leptomeningeal metastases (LM) in patients with breast cancer.
Many of the most aggressive and hard-to-treat cancers are highly effective at blocking T cells, known as the foot soldiers of the immune system, from reaching and responding to tumors.
High levels of two specific vaginal bacteria (Atopobium vaginae and Gardnerella vaginalis) serve as diagnostic markers of an abnormal vaginal microbiota that might cause impaired implantation and subsequent poor reproductive outcome.
› Verified 7 days ago
Bram Sakdiponephong, MS, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2830 Easton Ave, Bethlehem, PA 18017 Phone: 484-526-3555 Fax: 833-822-5230 | |
Hazem Fahmy, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-6643 Fax: 484-526-4658 | |
Faton Bilali, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2300 Highland Ave, Bethlehem, PA 18020 Phone: 610-861-8080 | |
Maria Ghetu, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2830 Easton Ave, Bethlehem, PA 18017 Phone: 610-954-3555 Fax: 610-954-3560 | |
Jose G Guzman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-6048 Fax: 484-526-6500 | |
Neil B. Matalia, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2830 Easton Ave, Bethlehem, PA 18017 Phone: 484-526-3555 Fax: 484-526-3693 |